Promising indications that the gene-editing tool called CRISPR can be used to effectively fight cancer and other serious health disorders and diseases is about to put to the test in clinical trials. Samira Kiana, a Fulton Schools assistant professor of biomedical engineering and an expert in gene therapy, describes the complex obstacles and challenges involved in verifying CRISPR’s curative powers.